The dysbindin gene in major depression: An association study

American Journal of Medical Genetics - Neuropsychiatric Genetics

Volumn 129 B, Issue 1, 2004, Pages 55-58

  Zill, Peter ^a   Baghai, Thomas C ^a   Engel, Rolf ^a   Zwanzger, Peter ^a   Schüle, Cornelius ^a   Eser, Daniela ^a   Behrens, Stefanie ^a   Rupprecht, Rainer ^a   Möller, Hans Jürgen ^a   Ackenheil, Manfred ^a   Bondy, Brigitta ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Association study; Dysbindin; Haplotype analysis; Major depression; SNP; Treatment response

Indexed keywords

ANTIDEPRESSANT AGENT; BINDING PROTEIN; DYSTROBREVIN; DYSTROBREVIN BINDING PROTEIN 1; DYSTROPHIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DRUG RESPONSE; DYSBINDIN GENE; FEMALE; GENE; GENE EXPRESSION; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PRIORITY JOURNAL; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; STATISTICAL ANALYSIS;

EID: 3342950092     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.30064     Document Type: Article

References (24)

1. Benson MA, Newey SE, Martin-Rendon E, Hawkes R, Blake DJ. 2001. Dysbindin, a novel coiled-coil-containing protein that interacts with the dystrobrevins in muscle and brain. J Biol Chem 276:24232-24241.
2. Blake DJ, Hawkes R, Benson MA, Beesley PW. 1999. Different dystrophin-like complexes are expressed in neurons and glia. J Cell Biol 147:645-658.
3. Brambilla P, Perez J, Barale F, Schettini G, Soares JC. 2003. GABAergic dysfunction in mood disorders. Mol Psychiatry 8:721-737.
4. Bredt DS. 1999. Knocking signalling out of the dystrophin complex. Nat Cell Biol 1:E89-E91.
5. Crow TJ. 1995. A continuum of psychosis, one human gene, and not much else - the case for homogeneity. Schizophr Res 17:135-145.
6. D'Sa C, Duman RS. 2002. Antidepressants and neuroplasticity. Bipolar Disord 4:183-194.
7. Duman RS, Malberg J, Nakagawa S, D'Sa C. 2000. Neuronal plasticity and survival in mood disorders. Biol Psychiatry 48:732-739.
8. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, Higgins J, DeFelice M, Lochner A, Faggart M, Liu-Cordero SN, Rotimi C, Adeyemo A, Cooper R, Ward R, Lander ES, Daly MJ, Altshuler D. 2002. The structure of haplotype blocks in the human genome. Science 296: 2225-2229.
9. Gould TD, Manji HK, 2002. Signaling networks in the pathophysiology and treatment of mood disorders. J Psychosom Res 53:687-697.
10. Grady RM, Zhou H, Cunningham JM, Henry MD, Campbell KP, Sanes JR. 2000. Maturation and maintenance of the neuromuscular synapse: Genetic evidence for roles of the dystrophin-glycoprotein complex. Neuron 25:279-293.
11. Knuesel I, Mastrocola M, Zuellig RA, Bornhauser B, Schaub MC, Fritschy JM. 1999. Short communication: Altered synaptic clustering of GABAA receptors in mice lacking dystrophin (mdx mice). Eur J Neurosci 11:4457-4462.
12. Krystal JH, Sanacora G, Blumberg H, Anand A, Charney DS, Marek G, Epperson CN, Goddard A, Mason GF. 2002. Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments. Mol Psychiatry 7(Suppl 1):S71-S80.
13. Lewontin RC. 1988. On measures of gametic disequilibrium. Genetics 120: 849-852.
14. Longmate JA. 2001. Complexity and power in case-control association studies. Am J Hum Genet 68:1229-1237.
15. Maier W, Rietschel M, Lichtermann D, Wildenauer DB. 1999. Family and genetic studies on the relationship of schizophrenia to affective disorders. Eur Arch Psychiatry Clin Neurosci 249(Suppl 4):57-61.
16. Maier W, Lichtermann D, Franke P, Heun R, Falkai P, Rietschel M. 2002. The dichotomy of schizophrenia and affective disorders in extended pedigrees. Schizophr Res 57:259-266.
17. McLeod TM, Lopez-Figueroa AL, Lopez-Figueroa MO. 2001. Nitric oxide, stress, and depression. Psychopharmacol Bull 35:24-41.
18. Morris DW, McGhee KA, Schwaiger S, Scully P, Quinn J, Meagher D, Waddington JL, Gill M, Corvin AP. 2003. No evidence for association of the dysbindin gene [DTNBP1] with schizophrenia in an Irish population-based study. Schizophr Res 60:167-172.
19. Schneider S, Rössli D, Excoffier L. 2000. Arlequin: A software for population genetics data analysis. Version 2.000. Geneva: Genetics and Biometry Laboratory, Department of Anthropology, University of Geneva.
20. Schwab SG, Knapp M, Mondabon S, Hallmayer J, Borrmann-Hassenbach M, Albus M, Lerer B, Rietschel M, Trixler M, Maier W, Wildenauer DB. 2003. Support for association of schizophrenia with genetic variation in the 6p22.3 gene, dysbindin, in sib-pair families with linkage and in an additional sample of triad families. Am J Hum Genet 72:185-190.
21. Spitzer RL, Williams JB, Gibbon M, First MB. 1992. The Structured clinical interview for DSM-III-R (SCID). I: History, rationale, and description. Arch Gen Psychiatry 49:624-629.
22. Straub RE, Jiang Y, MacLean CJ, Ma Y, Webb BT, Myakishev MV, Harris-Kerr C, Wormley B, Sadek H, Kadambi B, Cesare AJ, Gibberman A, Wang X, O'Neill FA, Walsh D, Kendler KS. 2002. Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia. Am J Hum Genet 71: 337-348.
23. Turner D, Choudhury F, Reynard M, Railton D, Navarrete C. 2002. Typing of multiple single nucleotide polymorphisms in cytokine and receptor genes using SNaPshot. Hum Immunol 63:508-513.
24. van den Oord EJ, Sullivan PF, Jiang Y, Walsh D, O'Neill FA, Kendler KS, Riley BP. 2003. Identification of a high-risk haplotype for the dystrobrevin binding protein 1 (DTNBP1) gene in the Irish study of high-density schizophrenia families. Mol Psychiatry 8:499-510.